A Hydrogel/Carbon-Nanotube Needle-Free Device for Electrostimulated Skin Drug Delivery by Guillet, Jean-François et al.
  
 
 
OATAO is an open access repository that collects the work of Toulouse 
researchers and makes it freely available over the web where possible 
Any correspondence concerning this service should be sent  
to the repository administrator: tech-oatao@listes-diff.inp-toulouse.fr 
This is an author’s version published in: http://oatao.univ-toulouse.fr/21001 
 
To cite this version:  
Guillet, Jean-Fran�ois  and Flahaut, Emmanuel  and Golzio, 
Muriel A Hydrogel/Carbon-Nanotube Needle-Free Device for 
Electrostimulated Skin Drug Delivery. (2017) ChemPhysChem, 
18 (19). 2715-2723. ISSN 1439-4235  
Official URL: https://doi.org/10.1002/cphc.201700517 
 
A Hydrogel/Carbon-Nanotube Needle-Free Device for
Electrostimulated Skin Drug Delivery
Jean-FranÅois Guillet,[a, b] Emmanuel Flahaut,*[a] and Muriel Golzio*[b]
1. Introduction
The natural permeability of the skin allows selective passive
diffusion across the epidermis to reach blood vessels. The char-
acteristics of the skin (age, location and integrity) and of the
penetrants (size, solubility and charge) affect the kinetics of
percutaneous penetration.[1] Small amphiphilic molecules such
as nicotine (ca. 163 Da) are able to permeate through the skin
thanks to their hydrophilic and hydrophobic parts. In order to
achieve transdermal delivery of larger and more hydrophilic
molecules such as insulin or plasmid DNA, permeability of the
skin and mainly the permeability of stratum corneum has to be
increased. Therefore, developing a transdermal drug delivery
(TDD) system is a challenging task considering the selective
permeability of the skin and the physicochemical properties of
the drugs. Advancements in TDD systems are possible at differ-
ent levels by judicious selection of drugs that can cross the
skin at therapeutic rates without enhancement, by increasing
skin permeability and driving forces for transdermal transport
of small molecules or by enabling transdermal delivery of small
and large hydrophilic drugs through targeted permeabilisation
of the stratum corneum of the skin.[2, 3] In order to overcome
the skin barrier, different drug delivery devices have been de-
signed to deliver drug molecule by using physical methods
such as electrical devices, optical devices, high-pressure devi-
ces, acoustic, thermal and microneedles devices.[4–6] Some of
them exhibit a significant increase in delivery of macromole-
cules across the skin. More precisely, a method named “electro-
permeabilisation” or “electroporation” has been shown to
strongly increase skin permeability. This is a physical method
where the application of electric pulses by means of electrodes
is used to transiently increase the permeability of the cell
membrane so that large molecules can enter into the cells.[7]
The method was developed in the 1980s[8] and has since
evolved to be used in the routine transfection of cells in vitro
and different tissues, including tumours in vivo.[9–13] During
electroporation of the skin, the stratum corneum (SC) is modi-
fied leading to increases in electrophoretic mobility, molecular
diffusivity, and electrical conductivity. It has been observed
that high voltage pulsed electric fields can be more effective in
enhancing transdermal flux of drugs in comparison with con-
tinuous application of low voltage pulses as in the case of ion-
tophoresis.[14] Electroporation-assisted transdermal transport
depends on the shape, pulse repetition rate, amplitude, dura-
tion, number of electric pulses, electrode design, as well as the
distance between electrodes.[15–20] Earlier works proposed the
creation of “pores” or aqueous pathways due to the electropo-
ration procedure. The evolution of these pores was investigat-
ed by measurements of the electrical properties of the skin
during pulse application.[21,22] Short duration and high intensity
pulses led to an alteration of the stratum corneum with nano-
to micrometre-sized aqueous “pores”, whereas long duration
and medium intensity pulses increased the permeability within
the stratum corneum through large pores (up to hundreds of
mm) but with lower density.[23] The applied electric field pro-
vides an electrophoretic force for delivering molecules across
the induced pores within the stratum corneum. Electrophoresis
is the major component in the delivery of charged and large
molecules across the skin.[24,25] Electroporation mediated-TDD
fully depends on the injection of the drug and on the type of
electrodes used to enhance the permeability of the skin. To im-
prove patient compliance, that is, avoid needle phobia, the ap-
plication of a patch would be more likely accepted due to
painlessness ability and as well for discretion. Other devices
such as intradermal microneedle or multi-electrode arrays
(MEA)[26,27] have been designed to increase permeability of skin
and reduce pain for patients.[28] Effect of the electric field on
drug diffusion was investigated to control drug delivery using
different kinds of fluorescent molecules with various molecular
weights, such as fluorescein isothiocyanate dextran (FITC).[29]
MEA devices showed an effective result on enhancement of
plasmid expression for DNA vaccination.[27] Nevertheless, alter-
The permeability of skin allows passive diffusion across the epi-
dermis to reach blood vessels but this is possible only for
small molecules such as nicotine. In order to achieve transder-
mal delivery of large molecules such as insulin or plasmid
DNA, permeability of the skin and mainly the permeability of
the stratum corneum skin layer has to be increased. Moreover,
alternative routes that avoid the use of needles will improve
the quality of life of patients. A method known as electroper-
meabilisation has been shown to increase skin permeability.
Herein, we report the fabrication of an innovative hydrogel
made of a nanocomposite material. This nanocomposite
device aims to permeabilise the skin and deliver drug mole-
cules at the same time. It includes a biocompatible polymer 
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native devices avoiding the use of needles will improve the
quality of life of patients during chronic administration and/or
during vaccination. These devices should have two main prop-
erties: first having conductive properties in order to be used as
electrodes and second being a reservoir for the drug to be de-
livered. Hydrogels are commonly used in drug delivery system
thanks to their hydrophilic nature.[30,31] They also own many
useful properties such as swelling, great biocompatibility, low
toxicity (if any) and possible biodegradability if desirable. Fur-
thermore, these polymers may be cross-linked by different
methods such as addition of poly electrolytes, pH variation,
heating or by irradiation.[32] In recent years, scientists have de-
veloped a wide range of innovative nanocomposite hydrogels
by the addition of different nanoparticles such as gold, iron
oxide, hydroxyapatite, and of course carbon nanomaterials in-
cluding carbon nanotubes.[33,34]
Carbon nanotubes (CNTs) are an allotrope of carbon in the
form of cylindrical all-carbon molecules.[35] CNTs, and especially
double-walled-carbon-nanotubes (DWCNTs),[36] are ideal candi-
dates for many applications, combining high electrical conduc-
tivity with a very high specific surface area (ca. 1000 m2g@1) to-
gether with a good biocompatibility when included into a ma-
terial, or deposited on a surface.[37] They can be incorporated
into different polymers in order to prepare nanocomposite ma-
terials. Actually, only a few papers report the use of CNTs in
various experimental configurations for electro-stimulated
drug delivery. For example, an in vitro study evaluated the
transdermal delivery of clonidine (ca. 230 Da) mediated by a
CNT-epoxy nanocomposite membrane by applying various
electrical biases.[38] Servant et al. reported the fabrication of
two different carbon-based hydrogel nanocomposites with
graphene based[39] or multi-walled CNTs[40] for in vivo pulsatile
(low voltage) drug delivery systems (DDS). These devices were
subcutaneously implanted and stimulated with electric field.
Although these strategies are rather different from our work,
they demonstrate the feasibility and high potential of applica-
tion of CNTs (and nanocarbons in general) for electrostimulat-
ed drug delivery.
Here, we report the fabrication of an innovative needle-free
device, made of DWCNTs-containing nanocomposite material.
This nanocomposite device aims at permeabilising skin and de-
livering drug molecules simultaneously. It includes a biocom-
patible polymer matrix (hydrogel of agarose) and DWCNTs in
order to improve both mechanical and electrical properties.
The aim of this study was to prepare a DWCNT bio-based
nanocomposite hydrogel, and its characterization in terms of
structural organization, storage capacity and electrical proper-
ties. Finally, we show its first use as a TDD system after electro-
stimulation using an ex vivo mouse skin model and a 4 kDa
fluorescent FITC-dextran used as a control molecule. These en-
couraging results provide good evidence that the use of
DWCNTs improves the transdermal delivery potentialities of
the biocompatible polymer matrix.
2. Results and Discussion
2.1. Device Characterization
We first performed visual observations of CTRL-AG (Agarose)
and DWCNT-AG (DWCNT-Agarose) hydrogel materials. Hydro-
gels were prepared using deionized (DI) water with 2.5 wt./v of
agarose with 0, 0.1, 0.5, 1 wt.% of DWCNTs (DWCNT-AG hydro-
gels). After gelation, samples were deposited on a dry absorb-
ing paper for macroscopic observation. As the concentration
of DWCNTs increased, transparency of the hydrogel decreased
and they became darker (Figure 1a). After the drying step and
the swelling step (Figure 1b), the weight, thickness and diame-
ter of DWCNT hydrogels were measured (Figure 2).
2.2. Drying, Swelling and Morphological Characterization
Deformation of the material can occur during the drying step,
and should be limited as much as possible. Many parameters
such as temperature and hygrometry play a major role, as well
as the nature of the interface with the substrate. After compar-
ing different drying conditions (including the comparison be-
tween substrates of different nature such as glass, silicon
wafer, Teflon, and various metals), we finally dried the hydro-
gels on a stainless steel substrate (INOX309) at 20–25 8C for
24 h at atmospheric pressure (Figure 1b for DWCNT-AG, and
Figure S1 for CTRL-AG). The weight, thickness and diameter of
DWCNT hydrogels were measured (Figure 2a). We obtained
similar results for CTRL-AG hydrogel and DWCNT-AG (1 wt.%
DWCNT) hydrogel nanocomposite samples with 97% and
96.7% of water weight loss, resp. Thickness losses of 88.4%
Figure 1. Visual characterization of hydrogel nanocomposite device. a) Mac-
roscopic visualization of CTRL-AG hydrogel (agarose alone, 0% CNTs),
0.1 wt.%, 0.5 wt.% and 1 wt.% of DWCNTs in AG hydrogel nanocomposite.
Scale bar=5 mm. b) Picture of 1 wt.% DWCNT-AG hydrogel nanocomposite
after manufacturing, drying and swelling in PBS.
and 92.2% were observed for CTRL-AG hydrogel and DWCNT-
AG hydrogel nanocomposite, resp. Interestingly, the diameter
decrease was only 16.6% in the presence of DWCNTs (28.3% in
CTRL-AG), showing that the presence of DWCNTs in agarose
absorbs deformation strains during the drying step. This me-
chanical strengthening thanks to the presence of DWCNTs
mainly affects the diameter. This is important because this rep-
resents the surface which will be in contact with the skin
during drug delivery.
Figure 2b shows recovery after 24 h of swelling step in
phosphate buffer saline (PBS). Samples absorbed about the
same amount of liquid (22% and 21% water weight for CTRL-
AG and DWCNT-AG, resp.) Regarding the thickness, the gain
was lower in the presence of DWCNTs (34% versus 44% for
CTRL-AG) and the final diameter was also closer to that of the
initial material in the presence of DWCNTs (86.6% versus
76.6% for CTRL-AG).
These results demonstrate that the presence of DWCNTs did
not affect water weight recovery, and thus the capacity of the
material to absorb and store a drug solution. Altogether, our
results show that our device can be used as a drug reservoir.
Moreover, our method allows to limit diameter deformation
and to maximize surface contact of the hydrogel with the skin
and the electrode connections.
2.3. SEM Characterization
In order to assess the dispersion of DWCNTs in the polymer
matrix (1 wt.% DWCNT-AG hydrogel), we performed FEG-SEM
observation of the dry hydrogel nanocomposite. This revealed
a high roughness topography at the surface of the sample, de-
picted in Figure 3a. DWCNTs were located under a thin layer of
polymer (better evidenced in the inset in Figure 3a) attributed
to a “skin effect” between polymer and DWCNTs, probably in-
duced throughout the thermal gelation step of agarose. Ac-
tually, this very thin layer between surface and bulk material
may correspond to an insulating part, expected to bring a po-
tential capacitive barrier to our nanocomposite material. Fig-
ure 3b shows a magnification of the surface evidencing
DWCNTs bundles, demonstrating clearly the efficient dispersion
of the nanotubes. We also observed non-uniform agglomer-
ates indicated by white arrows and corresponding to disorgan-
ized carbon, initially present in the DWCNT material. Figure 3c
shows more details at higher magnification of the surface,
where disorganized carbon (ca. 0.05–1 mm) and DWCNTs bun-
dles indicated by white arrow (ca. 10–100 nm) are clearly visi-
Figure 2. Characterization of the deformations of the CTRL-AG hydrogel and
DWCNT-AG hydrogel nanocomposite (1 wt.% DWCNT) after drying and swel-
ling (24 h in PBS) steps. a) Weight, thickness and diameter losses after the
drying step for the CTRL-AG hydrogel and DWCNT-AG hydrogel nanocompo-
site [dry state/ initial state, calculated from Eq. (1)] ; b) Weight, thickness and
diameter recovery after the swelling step in PBS for the CTRL-AG hydrogel
and DWCNT-AG hydrogel nanocomposites (swollen state/ initial state [calcu-
lated from Eq. (1)] .
Figure 3. Microstructural characterization of hydrogel nanocomposites. SEM
image of 1 wt.% DWCNT-AG hydrogel nanocomposite; a,b, c) Surface topog-
raphy at X1000/X15000/X40000; c,d, e) Cross-sectional topography of hydro-
gel nanocomposite at X1000/X15000/X40000. Scale bars=10 mm (a,d), 1 mm
(b,e), 100 nm (c, f).
ble. Figure 3d,e show a cross-section of the same sample evi-
dencing a 3D hydrogel network formed by a superposition of
agarose layers. Similarly, to what was evidenced at the surface,
Figure 3 f shows many DWNCTs bundles throughout the hydro-
gel nanocomposite, also evidencing a very efficient dispersion
of the nanotubes across the matrix. These observations con-
firmed that the preparation process was reproducible and effi-
cient, also suggesting that the DWCNT-AG hydrogel nanocom-
posite network was already interconnected at the gelling step
suggesting that physical percolation in the dry state was
reached. However, it is difficult to extrapolate the actual perco-
lation conditions in the swollen state because the expansion of
the material may lead to significant differences between the
dry and wet states. It is also important to note that the incor-
poration of a large amount of water also modifies the actual
CNT ratio within the material (significant decrease).
2.4. Swelling Behaviour
Because we hypothesize the possible use of this material for
delivering different types of drugs or macromolecules, we in-
vestigated more in details its swelling behaviour in different
media (deionised water, PBS) and at different pH values. The
swelling ratio (gg@1) in PBS was quantified as a function of
time in Figure 4a. We observed for both samples a rapid swel-
ling within the first 50 minutes to reach a plateau. The inset in
Figure 4a shows a magnification of the swelling during the
first hour and illustrates the influence of DWCNTs which slow-
down the swelling for DWCNT-AG already after 10 min, proba-
bly because the presence of the nanotubes increases the stiff-
ness of the polymer network. Swelling reached the maximum
values of 6.4 gg@1 and 5.5 gg@1, for CTRL-AG and DWCNT-AG
hydrogels, respectively, after 24 h.
At the final swelling state (24 h), the hydrogel were consid-
ered as full, because samples could not expand substantially
more. Only 1 gg@1 difference was observed between CTRL-AG
and DWCNT-AG in terms of swelling. We suppose that swelling
restriction was induced by the drying step and we suggest
drying stress leading to an aggregation of the agarose chains
throughout the matrix. Regarding the recovery ratio upon
swelling, no variation was observed throughout the investigat-
ed pH range (Figure 4b). Sweeping pH value evidenced an op-
erating window in terms of pH stability of our devices, which
was expected for agarose. We recovered between 22.2%
(CTRL-AG hydrogel) and 21.4% (DWCNT-AG) of the initial value
in PBS.
2.5. Release Properties
As the device will be applied on the skin, we tested the hy-
pothesis of a passive release from our samples. For that we
used artificial sweat in order to mimic extreme physiological
conditions. Samples were incubated in artificial sweat at 50 8C
to mimic a worst-case condition. The quantification of fluores-
cein isothiocyanate dextran (FITC-D) molecules release from
the hydrogel was performed by fluorescence spectroscopy
(Figure 5a). From weight measurements between the dry and
Figure 4. Swelling characterization for CTRL-AG hydrogel and DWCNT-AG hy-
drogel nanocomposite. a) Weight swelling ratio in PBS as function of time
for CTRL-AG hydrogel and DWCNT-AG [1 wt.% DWCNTs, calculated from
Eq. (1)] . b) Swelling recovery percentages as a function of different pH values
ranging from 3 to 7 and in PBS solution (pH 7.4) at 24 h [swollen state/ ini-
tial state, calculated from Eq. (2)] .
Figure 5. Release characterization of CTRL-AG hydrogel and DWCNT-AG hy-
drogel nanocomposite. a) Spectrophotometry measurement of the FITC-D
release due to release % versus time from CTRL-AG hydrogel and DWCNT-
AG hydrogel nanocomposites (1 wt.% DWCNTs) under stirring conditions
over 60 min at 1 mm FITC-D concentration. b) Expanded portion showing
the transitory area.
the swollen states, the amount of FITC-D (mol) initially loaded
inside the hydrogel was calculated from an initial concentra-
tion of 1 mm FITC-D in PBS and reported in Table 1. We also
calculated the amount released, and finally the release ratio.
Release versus time was plotted in Figure 5. The presence of
DWCNTs did not significantly modify the release kinetics and in
both cases, almost 70% of the FITC-D was passively released in
about 15 min (Figure 5b), after what the phenomenon clearly
slowed down with a slower release kinetics for the DWCNT-AG
hydrogel (15 min). The maximum release reached ca. 94%
within one hour. These results thus indicate that although the
presence of DWCNTs influences the deformation upon drying,
the nanotubes seem to play no obvious role in terms of pas-
sive release from the swollen material in these extreme condi-
tions (100% artificial sweat and continuous stirring), very far
from a realistic scenario.
2.6. Electrical Characterization
Electrical impedance spectroscopy (EIS) measurements re-
vealed an ionic conductivity related to the presence of PBS so-
lution inside the hydrogel materials (swollen), as shown in
Figure 6. EIS measurement is an easy method to determine if
DWCNT percolation threshold was reached. We measured a re-
sistivity of 362 Ohm (2.7 mscm@1) for CTRL-AG hydrogel while
the resistivity of the DWCNT-AG hydrogel nanocomposite was
slightly lower at 307 Ohm (3.2 mscm@1). Although microscopy
observations (Figure 3) revealed a good dispersion of DWCNT
through the hydrogel nanocomposite, EIS measurement did
not clearly evidence any percolation phenomena in the swol-
len state. Absence of a percolation threshold even at 1 wt.%
loading of DWCNTs is surprising. Indeed, earlier work of our
group involving the same DWCNTs but with a different matrix
(Polyepoxy[41]) revealed that the percolation threshold was
reached at a much lower concentration (0.3 wt.%). However,
the situation is indeed quite different here for many reasons:
(1) the nanocomposite is not composed of only 2 phases (poly-
mer matrix and CNT load), but 3 phases because the swollen
nanocomposite is mainly composed of a third phase, which is
water ; (2) although the ratio of CNTs is 1 wt.% versus the poly-
mer, the actual load in the swollen material is only 0.12 wt.%
of the total mass (H2O/polymer). EIS measurements performed
in PBS before the drying step (Figure S2) evidenced the same
behaviour, namely the absence of a percolation threshold. We
observed an ionic dominant conduction behaviour for DWCNT-
AG. Likewise, we observed a modest decrease in terms of ionic
conductivity for DWCNT-AG, when we expected DWCNTs to
create new and more efficient pathways through the hydrogel
for ionic species, supposed to lead to an increase in ionic mo-
bility. The electrical characterization measurement conditions
are very far from the electroporation ones, indeed intensity of
applied electric field could induce structural modification
through the DWCNT-AG hydrogel nanocomposite network.
The complexity of such a triphasic system (water/polymer/
CNTs), especially in regard of electrical percolation of DWCNTs
must be investigated by complementary techniques (currently
in progress). EIS measurement method brings a first approach
to understand the electrical behaviour of our nanocomposite
hydrogel.
2.7. Skin Electroporation
Electro-stimulated release of FITC-D from 1 wt.% DWCNT-AG
hydrogel nanocomposite and CTRL-AG hydrogel as a control
were performed by electroporation on fresh mouse skin
sample in order to break the highly resistive stratum corneum
barrier layer.[42] In the absence of an electric field (Figure 7a,d),
very weak fluorescence was observed on the skin after 30 min
of incubation suggesting that our device did not release much
FITC-D without external stimulation. This means that when
compared to the passive release observed in extreme condi-
tions (total immersion in 100% artificial sweat and mechanical
stirring), the 30 minutes’ application on the skin did not lead
to a drastic release of the FITC-D molecules. When electrical
stimulation (10 pulses of 20 ms at 1 Hz frequency and 300 V)
was applied an immediate contraction of mouse skin, corre-
sponding to the electrical stimulation of the skin muscles lo-
cated below the dermis skin layer, was observed. After 30 min,
we observed as a result two fluorescent marks corresponding
to the cathode (@) and the anode (+) positions (Figures 7b,e).
Observation on the cathode electrode side revealed a strong
fluorescent signal due to electrostimulation applied on the
device, when in contrast only a weak fluorescence staining
could be observed at the positive pole. Figure 7e clearly re-
Table 1. Quantification of storage after swelling/release in CTRL-AG and
DWCNT (1% wt. DWCNT)-AG hydrogels (1 mm FITC-D).
Sample FITC-D
(swollen state) [mol]
FITC-D
(released) [mol]
Release
[%]
DWCNT-AG 2.93V10@8 2.61V10@8 89.2
CTRL-AG 2.83V10@8 2.66V10@8 94.2
Figure 6. EIS characterization of the CTRL-AG and DWCNT-AG hydrogels
(1 wt.% DWCNTs) in the swollen state. a) Measurement of ionic resistivity of
CTRL-AG hydrogel and DWCNT-AG hydrogel nanocomposite. b) Expanded
portion showing the low Z’ range. Swollen hydrogels (24 h in PBS) were
placed between two stainless steel electrodes and analysed in the range
1 Hz–1 MHz with an applied AC voltage of 100 mV at room temperature.
veals the electric field distribution in the case of the DWCNT-
AG nanocomposite, with the expected presence of a fluores-
cent crescent on the electrodes’ sides. These crescents reflect
the electric field distribution intensities. Indeed, the electric
field intensity is defined as the ratio between the applied volt-
age and the distance between the electrodes.[8, 18, 28] Intensities
were maximum between the two electrodes and decreased as
the distance between the electrodes increased. Moreover, the
circumference of electrodes exhibited higher fluorescence in-
tensity. This increase may be due to the fact that the edges of
the electrode were rough all-around the patch. In fact, we ob-
serve the formation of this roughness during the drying step.
This may induce a “tip effect” on skin when electric field is ap-
plied. A stronger fluorescence staining was observed with the
DWCNT-AG nanocomposite, unambiguously evidencing the
role played by DWCNTs. We can thus expect a more effective
destabilization of stratum corneum layer due to higher current
density flow, combined with a more effective release of the
FITC-D molecules. Visualization at higher magnification of the
skin (Figure 7 f) revealed different structures such as hair folli-
cles, marked wrinkles but also hexagonal nest-like shapes
showing penetration through the stratum corneum. We can
assume that the FITC-D molecule reached different stratum cor-
neum layers according to the depth of penetration, but more
intense or different kind of stimulations (such as iontophoresis
or electrophoresis) is probably required to reach the sublayer
skin and finally the blood circulation. The visualization of these
hexagonal nests and the heterogeneous FITC-D distribution in-
dicate a dependence in terms of possible preferential path-
ways trough the stratum corneum layer.
To our knowledge, these experiments are the first evidences
of electropermeabilised mouse skin stratum corneum and re-
lease of FITC-D at the same time using such a device based on
agarose polymer. The presence of 1 wt.% of DWCNTs inside
the hydrogel is evidenced to significantly increase the penetra-
tion through the superficial layers of the skin.
However, there are earlier reports in the literature showing
that the presence of carbon nanotubes allows decreasing the
voltage threshold for electro-stimulated both in vitro and
in vivo drug delivery.[43,44] The authors describe the enhance-
ment of the electric field (tip effect) by the carbon nanotubes
as the main mechanism for the observed enhancement.
In our work, the carbon nanotubes are entrapped within the
hydrogel, and we have demonstrated (not shown) that even in
extreme conditions (artificial sweat at 50 8C), they are not re-
leased, so the mechanisms involved here are of a different
nature.
Increasing the electrical conductivity of the material is prob-
ably the reason why the delivery is improved. Thorough inves-
tigation of skin structure after electrostimulation is in progress
but still too preliminary to be included at this stage.
3. Conclusions
Addition of DWCNTs to an agarose hydrogel allows to prepare
a nanocomposite material which can be at the same time used
for storing a drug of interest and release it through the skin by
electrostimulation (electropermeabilisation). The presence of
the DWCNTs also improves the mechanical properties of the
material, without however modifying too much its behaviour
in terms of storage. Our process uses no solvent other than
water, and the DWCNTs are very well dispersed within the
agarose matrix. We have demonstrated the formulation of bio-
compatible electrodes for the transdermal delivery of large
(4 kDa) molecules through the stratum corneum by electro-
stimulation. Although our investigations are currently limited
to ex vivo data using a mouse skin model, we are convinced
that this new material and these preliminary results are very
promising for applications in the field of transdermal drug de-
livery. Work is in progress to optimize the electrostimulation
conditions, as the idea of the inclusion of carbon nanotubes is
also to be able to perform the delivery in much milder condi-
tions, more compatible with a realistic clinical use.
Experimental Section
Device Fabrication
Agarose (AG) was purchased from Sigma–Aldrich. Hydrogel was
prepared using deionised (DI) water so that the final concentration
of AG was 2.5 wt./v. %. After solubilisation of AG, the solution was
blended with DWCNTs at 0.1, 0.5, 1 wt.% of the polymer and pro-
cessed using a shear-mixer (IKA, Ultra-Turrax T10, 20 min, 80 8C).
Figure 7. Visualization of skin electroporation. Representative pictures of
mouse skin after electropermeabilisation with CTRL-AG and DWCNT-AG
(1 wt.% DWCNTs) containing 4 kDa FITC-dextran at 1 mm. Images (a,d) show
CTRL-AG and DWCNT-AG without electrical stimulation under identical con-
ditions at the same intensity level (X0, 57). Images in (b, e) are with electrical
stimulation: The anode is on the left-hand side and the cathode on the
right-hand side (magnification X0.57). c, f) Magnifications (X4) of the anode
area of (b, e), respectively. The frame on the left side of (c, f) pictures show a
numerical magnification X400.
DWCNTs were prepared according to Flahaut et al. 2003. The sus-
pensions were then poured into a Petri dish and cooled down to
ambient conditions (20–25 8C) for 30 minutes. After cooling, hydro-
gel nanocomposites were shaped into cylinders of 1 cm diameter
and 0.2 cm thickness, and placed into DI water (pH 5.5) bath in the
fridge for preservation. The overall elaboration process is shown
on Figure 8.
Characterization of the Device
Drying Method and SEM Preparation
Cylindrical samples were placed on a stainless steel (INOX-309)
plate and placed into an oven at 20 8C for 24 h at atmospheric
pressure. After the drying step, sample thickness was measured
using a thickness controller (KAEFER trademark BLET—10 mm di-
ameter). Microstructure of the DWCNT hydrogel : dry DWCNT-AG
hydrogel nanocomposite was first metallized by sputtering with
ca. 2 nm of platinum (Pt JEOL JFC-2300HR) and observed with FEG
SEM JEOL JSM 7800F Prime—EDS at 3 kV.
Swelling Measurements
Hydrogel sample was placed in a beaker and was immerged in
10 mL of buffer solution (phosphate citrate buffer Pearse 1980) at
25 8C with 4 different pH, respectively: 4, 5, 6, 7, and phosphate
buffer saline at pH 7.4 (PBS without Ca2+ and Mg2+—Eurobio).
Evaluation of swelling was performed to measure the weight gain
versus time. The hydrogel sample was quickly removed from the
beaker at different time intervals, and carefully blotted free of sur-
face water using classical filter paper, weighted on an analytical
balance (accuracy 0.0002 g), and reinserted into the swelling solu-
tion. The swelling ratio is defined as the fractional weight increase
of the hydrogel due to water absorption. It is calculated from the
following equation [Eq. (1)]:
w g?g@1ð Þ ¼ wt @ wd
wd
ð1Þ
Here, Wd, Wt, represent the weight of dried hydrogel material after
drying process at “t0”, the weight of hydrogel materials after swel-
ling at different pH values at time “t”.
The recovery-swelling ratio is defined as the fractional weight in-
crease of the hydrogel due to water absorption in relation to the
initial mass. The recovery is easily obtained from the swelling equa-
tion [Eq. (2)]:
% Recovery ¼ wt
wi
> 100 ð2Þ
Here, Wi, Wt, represent the weight of hydrogel materials before
drying and the weight of hydrogel materials after swelling at differ-
ent pH values at time “t”, respectively. Finally, to mimic the pene-
tration of a large molecule, we used FITC-D (average mol. wt.
3,000–5,000 Da) from Sigma–Aldrich. The nanocomposite was incu-
bated for swelling in 1 mm FITC-D in PBS.
Kinetics of Release Measurement
FITC-D molecules release was monitored in terms of kinetics and
content (concentration and release %). We used a fluorescence
spectrometer (Edinburg FLSP920, Excitation Ne: 490 nm BP:
0.8 nm—Emission Visible photomultiplier: 515 nm–1 nm) with a
quartz precision cell containing 3.5 mL of artificial sweat to mimic
physiological medium. Furthermore, we used magnetic stirring
(400 rpm) at ambient temperature (20–22 8C) to keep the solution
homogenous. To maintain the sample and monitor the release, we
designed and fabricated a nacelle in polylactic acid by 3D printing
(3D MakerbotT Replicator 2). Sample was carefully blotted free of
surface water using classical filter paper and placed inside the na-
celle. The final concentrations were determined by using a calibra-
tion curve from FITC-D (1 mm) solutions of known concentrations.
Electrical Characterization
Electrochemical impedance spectroscopy (EIS) measurements were
used to determine the resistivity of the nanocomposite material.
The solution resistance was obtained by using the Nyquist repre-
sentation and reading the Real axis part (Z’) value intercept and
Imaginary part (Z’’) relates to the capacitive part. The real axis (Z’)
value at the low frequency intercept is the sum of the polarization
resistance and the solution resistance. Prior to electrical measure-
ments, the hydrogel nanocomposite was quickly and carefully blot-
ted free of surface water using laboratory filter paper and put be-
tween two stainless steel electrodes. The relative resistivity was ob-
tained from impedance measurements using a 4294A Precision Im-
pedance Analyser (Agilent Technologies, Palo Alto, CA) in the
range of 1 Hz–1 MHz at room temperature and an applied AC volt-
age of 100 mV.
Electroporation of Mouse Skin
Fresh dorsal skins were withdraw from mice just after euthanasia
and immediately laid out on a homemade TeflonTM Franz cell
chamber filled with a PBS solution in the receptor compartment
(Figure 9a). The nanocomposite hydrogel electrode was placed on
the mouse skin (about 5 min after sacrifice) and covered by a thin
copper disk electrode (Figure 9b) connected to the generator
(ELECTRO cell B10 HVLV, Betatech, France) (Figure 9c). The inter-
electrode distance was set at 1.5 cm from the centre of each nano-
composite cylinder. Then, 10 square-wave pulses lasting 20 ms
Figure 8. Schematic representation of DWCNT-AG nanocomposite hydrogel
synthesis. a) Ultra-turrax dispersion of DWCNTs powder in 50 mL DI water for
20 min followed by sonication for 1 h at room temperature. b) Solubilisation
of agarose powder in 50 ml of DI water at 90–100 8C. c) Agarose/DWCNTs
blending directly followed by ultra-turrax homogenization for 20 min at 90–
100 8C. d) Formation of the hydrogel nanocomposite by gelation at room
temperature followed by die-cutting.
each, at a pulse repetition rate of 1 Hz, with an amplitude of 300 V,
were applied, respectively with CTRL-AG (Control hydrogel agar-
ose) and DWCNT-AG electrodes. Fluorescence optical imaging was
performed 30 minutes after pulses directly using a macroscope
(Macrofluo Leica). Selective excitation and emitted fluorescence of
FITC was obtained by a filter set GFP1 (Excitation 395–455 nm,
emission 480 nm LP Leica Macro Fluo—Source: Leica EL6000) and
detected with a CoolSnap HQ2 CCD camera (Roper Scientific,
France). Images were processed for contrast and brightness and
analysed with Image J (National Institute of Health, USA).
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Figure 9. Set-up for electroporation of mouse skin. a) Hairless mouse dorsal
skin was set on a homemade TeflonTM Franz cell chamber filled with PBS so-
lution in receptor ; (b) DWCNT-AG hydrogel was placed onto on the mouse
skin and connected using copper disks. The inter-electrode distance was set
at 1 cm from the centre of each nanocomposite cylinder, connected to stain-
less steel electrodes c) Electroporation generator (ELECTRO cell B10 HVLV).
